Abstract: ZBTB7A is a known proto-oncogene that is implicated in carcinogenesis and cell differentiation and development. Fully understanding the function of ZBTB7A in cellular processes could provide useful strategies for cancer treatment and development-associated disease therapy. Here, global mapping of ZBTB7A transcription factor binding sites was developed by utilizing microarray technology in HepG2 cells. The data obtained from the microarrays was further validated via chromatin immunoprecipitation-PCR (ChIP-PCR) and real time-PCR, and it was revealed that ZBTB7A may be one of the regulators of neural development. ZBTB7A target signal pathways were identified in signal pathway and GO (Gene Ontology) analyses. This is the first report on the global mapping of ZBTB7A downstream direct targets, and these findings will be useful in understanding the roles of ZBTB7A in cellular processes.
INTRODUCTION
ZBTB7A, also known as Pokemon, FBI [1] or LRF [2] , is a transcriptional factor that belongs to the POK protein family. The ZBTB7A gene has been shown to play roles in adipogenesis [3] , T-lymphoid lineage differentiation, terminal preadipocyte differentiation promotion [2] and carcinogenesis [4, 5] . Homozygous deletion of the ZBTB7A gene resulted in embryonic lethality in a mouse model, indicating that the ZBTB7A gene has an important physiological function. ZBTB7A can self-associate via both the POZ and zinc finger domains [6] , and it can also interact with BCL-6, another member of the POK protein family [7] . Considerable effort has been made to identify ZBTB7A target genes in order to elucidate the roles of ZBTB7A in carcinogenesis and cell differentiation and development. It has been shown that FBI-1 represses the transcription of some extracellular matrix genes [8] and suppresses the activity of the ADH5/FDH promoter [9] . Laudes et al. reported that ZBTB7A represses the expression level of E2F4 in a direct mechanism via ZBTB7A regulatory elements within the E2F4 promoter, and that the cyclin A expression level is reduced by ZBTB7A expression through an indirect mechanism without ZBTB7A binding to the promoter of the cyclin A gene [10] . The downregulation of the tumor suppressor Rb gene expression induced by ZBTB7A was found to be associated with the inhibition of C2C12 myoblast cell differentiation [11] . ZBTB7A was proved to be a critical factor in carcinogenesis when it was found to specifically repress the transcription of the tumor suppressor gene ARF through direct binding with the ARF promoter [4] . ZBTB7A was also found to activate the transcription of the fatty acid synthase gene (FASN) together with SREBP-1 [12] . To date, no high-throughput expression profiling had been applied to identify the ZBTB7A target genes. Chip is a powerful tool that identifies direct target genes by isolating DNA bound by proteins. When it was coupled with the microassay detection method (ChIP-chip), direct p53 and c-Myc binding loci on the genomes could be identified [13, 14] . Here, we performed a Zbtb7 ChIP-on-chip study on HepG2 cells, a cell line with a high endogenous ZBTB7A gene expression level, with the aim to delineate the ZBTB7A regulatory network.
MATERIALS AND METHODS

Cell culture
Cells of the human hepatocellular carcinoma cell line HepG2 were purchased from the American Type Culture Collection and were maintained in Dulbecco's modified Eagle's medium (DMEM, Gibco BRL) supplemented with 10% heated fetal bovine serum (FBS, Gibco, Grand Island, NY), 2 mM glutamine, 100 U/ml penicillin, and 100 μg/ml streptomycin at 37ºC, 5% CO 2 . Cells at 85-90% confluence were passaged by trypsinization.
Chromatin immunoprecipitation and genome-wide ChIP-chip
Chromatin immunoprecipitation and genome-wide location analysis were performed as described previously [15] . Briefly, HepG2 cells cultured to a confluence of 80% were treated with formaldehyde (1%) for 30 min, and the cells were collected by centrifugation, washed with ice-cold TBS, and disrupted by vortexing in a lysis buffer. The chromatin was sonicated to yield DNA fragments with an average length of 500 bp. The DNA fragments crosslinked to the proteins were enriched via immunoprecipitation with the ZBTB7A antibody (Abcam, ab36606, Cambridge, MA) and IgG (Abcam, ab37373, Cambridge, MA). After purification, the immunoprecipitated and input DNA were respectively labeled with Cy5 and Cy3 fluorescent dyes via ligation-mediated PCR. Both pools of labeled DNA were hybridized to Affymetrix GeneChip ® Tiling Arrays. Images of the Cy5 and Cy3 fluorescence intensities were scanned using a LuxScan-10KA laser confocal scanner (CapitalBio). The signal intensities for each spot were calculated by subtracting the local background using LuxScan 3.0 software (CapitalBio). For each microarray, linear normalization using a perchannel 50 th percentile method was adopted to get the ratio for each spot, and any fluorescence ratio over 2-fold higher than the norm was denoted as significant. The data from three independent experiments was combined for a statistical analysis using Student's t test.
Chromatin immunoprecipitation and PCR
An independent Chromatin Immunoprecipitation was performed on HepG2 cells, using the same methods as described above. The PCR primers for ZBTB7A target validation are listed in Tab. 1. Transient transfection of ZBTB7A targeting SiRNA into HePG2 cells Pokemon targeting siRNA (5'-GCUGGACCUUGUAGAUCAAtt-3', 5'-UUGAU CUACAAGGUCCAGCtt-3') was synthesized (GeneParma Co, Shanghai, China), and a scramble RNA was used as a control. For the siRNA delivery, HepG2 cells were mixed gently with siRNA and OligofectAMINE (Invitrogen, CA) in a volume of 0.5 ml according to the manufacturer's instructions, and incubated at 37ºC, 5% CO 2 for 4 h, followed by the addition of an equal volume of fresh medium containing 20% FBS. The cells were continuously incubated until harvest.
Real time-PCR analysis
Total RNA was prepared from cells using TRIzol reagent (Invitrogen, CA) according to the manufacturer's instructions. After being isolated, the RNA was reverse transcribed to cDNA using random primers (Promega, CA). The reaction mixture containing SYBR Green PCR Master Mix (TaKaRa, Dalian, China) was run in a 7500 real-time PCR System (Applied Biosystems, CA 
Western blot analysis
HepG2 cells transfected with pokemon targeting siRNA and scramble RNA were lysed on ice for 30 min with a lysis buffer consisting of 10 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid, 10 mM KCl, 1 mM ethylenediaminetetra acetic acid (EDTA; pH 8.0), 0.1% NP-40, 1 mM DTT, 1 mM PMSF, and 0.5 mM Na 3 VO 4 . Soluble protein (30 μg) was separated on a 12% sodium dodecyl sulfate-polyacrylamide electrophoresis gel and blotted onto a pure nitrocellulose membrane (Bio-Rad, Hercules, CA) at 180 mA for 2 h. After blockage with 5% skim milk in phosphate-buffered saline at room temperature for 45 min, the membranes were incubated with ZBTB7A antibody (1:500, Abcam) in the same buffer for 2 h, followed by incubation with goat anti-rabbit IgG (1:2000, Abcam) for 1 h. Antibody binding was detected using an enhanced chemiluminescence system (Pierce, Rockford, IL). To correct the protein loading amounts, the membranes were reprobed with β-actin monoclonal antibody (1:40,000; Sigma, St. Louis, MO).
RESULTS
Global mapping of ZBTB7A target genes in HepG2 cells
To identify ZBTB7A target genes in the human genome, cells of the human hepato-carcinoma cancer cell line HepG2 were used to perform ChIP-on-chip analysis. This cell line is an ideal cell model for global mapping of ZBTB7A target genes, because it has a high expression of ZBTB7A. The ZBTB7A-bound DNA fragments enriched by ChIP were subjected to microarray analysis, and 556 genes were identified to be potential direct targets of ZBTB7A in the HepG2 cells.
To obtain more detailed information, the set of 556 genes was further analyzed for their roles in pathways and biological processes with the Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Ontology (GO) databases using the Molecular Annotation System (MAS2.0) from CapitalBio. Of these genes, 423 had functional annotation and the rest did not have any annotation in GO with respect to biological processes. The potential ZBTB7A target genes were classified according to their physiological function (Fig. 1) . The results showed that the potential target genes of ZBTB7A mainly cluster to metabolism, transcription regulation and cell signal transduction. Of the 556 genes, 74 encoded for metabolic pathways, as shown in the KEGG database. Forty four metabolic pathways were compiled from the KEGG database, in which at least one gene was shown to be a potential direct target of ZBTB7A.
The most ZBTB7A-targeted cellular metabolic pathways include the aminosugar, arachidonic acid, tryptophan, pyrimidine and purine metabolic pathways. In addition, starch and sucrose metabolism, vitamin B6 metabolism, valine, leucine and isoleucine biosynthesis and degradation, folate biosynthesis, fatty acid metabolism and glycerolipid metabolism were shown to be potential regulatory targets of ZBTB7A. Fig. 1 . A functional classification of 556 genes identified as potential direct targets of ZBTB7A. The data obtained from a ChIP-on-chip assay of HepG2 cells was analyzed with the Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Ontology (GO) databases using Molecular Annotation System (MAS2.0) from CapitalBio. The ZBTB7A targeting pathways were then separated and classified based on their names as published in the KEGG to obtain a global view of the pathways regulated by ZBTB7A. The ZBTB7A-targeted main signaling pathways are presented in Tab. 2, and the results showed that 10 genes involved in the MAPK signaling pathway are potential targets of ZBTB7A, which suggests that ZBTB7A might be an important regulatory factor in the MAPK signaling pathway. Axon guidance, a key stage in the formation of the neuronal network, was also found to be partly regulated by ZBTB7A: five genes in this biological process were identified to be potential targets of ZBTB7A. Those results strongly suggest an important role of ZBTB7A in the regulation of cell proliferation and differentiation.
Validation of the ZBTB7A direct target genes involved in the axon guidance process To further confirm the results obtained from the ChIP-on-chip assay, five axon guidance process-associated genes, CFL1, RGS3, DPYSL2, LRRC4C and SEMA4B, were chosen for verification by ChIP-PCR in HepG2 cells. It was revealed that the consensus sequence G(A/G)GGG(T/C)(C/T)(T/C)(C/T) and the single guanine-rich sites are the preferable binding sites of ZBTB7A [16] . The PCR primers were designed according to the above criteria for the amplification of ZBTB7A antibody-enriched promoter fragments. As shown in Fig. 2A , ZBTB7A was shown to directly bind with the promoters of the CFL1, SEMA4B, RGS3 and DPYSL2 genes, while no binding was observed between ZBTB7A and the promoter of the LRRC4C gene. To further understand the role of ZBTB7A in the transcription regulation of the above genes, real time-PCR was performed in HepG2 cells with ZBTB7A knockdown induced by ZBTB7A targeting siRNA. As shown in Fig. 2B , the knockdown of ZBTB7A resulted in a decrease in the level of CFL1 and RGS3 gene transcription and an increase in the transcription activity of the DPYSL2 and SEMA4B genes in HepG2 cells. Those results provide evidence for the effect of ZBTB7A on the transcription regulation of genes involved in the axon guidance process.
DISCUSSION
In this study, by using a high-throughout microarray, we obtained a global map of the binding sites of ZBTB7A in cells of HepG2, a human hepato-carcinoma cell line with a high level of ZBTB7A expression. More than 500 genes were identified to be potential direct targets of ZBTB7A, and those genes were denoted and classified by utilizing pathway study and GO analysis software. Of the ZBTB7A-targeted genes, 74 genes clustered to metabolic pathways, and 44 of those metabolic pathways (including nucleic acid synthesis, fatty acid metabolism and sugar degradation) were shown to be associated with ZBTB7A, indicating that ZBTB7A is a critical regulator in cellular physiological processes. Currently, ZBTB7A is known as a proto-oncogene, as serial studies have revealed a correlation between ZBTB7A and carcinogenesis [4, 5, 11] . Maeda et al. reported that ZBTB7A shows a high expression level in T-cell and B-cell lymphoma cases, and that ZBTB7A overexpression leads to oncogenic transformation in mouse embryonic fibroblasts both in vitro and in vivo in transgenic mice [4] . ZBTB7A was also found to have become overexpressed in non-small cell lung cancer due to the gene amplification event [5] . Although the role of ZBTB7A in carcinogenesis has been confirmed by various research groups, other functions of ZBTB7A in human B versus T lymphocytes and human and murine preadipocyte differentiation was also proposed [2] . The different roles of ZBTB7A in the regulation of cellular behavior suggest that ZBTB7A is a multi-functional protein, and our data from the global microarray screening of ZBTB7A direct target genes also provides important evidence that ZBTB7A is not only a carcinogenesis-associated gene but also a necessary gene for cellular metabolism regulation, cell differentiation and embryonic development. This notion is supported by the fact that homozygous deletion of ZBTB7A resulted in embryonic lethality due to severe anemia in a mouse model [2] . To validate the results obtained from the microarray, five genes involved in axon guidance were chosen for ChIP-PCR and real time-PCR. ZBTB7A was shown to have a direct binding with the promoters of the CFL1, SEMA4B, RGS3 and DPYSL2 genes, and no binding was observed between the ZBTB7A and LRRC4C promoter in HepG2 cells. The Q-PCR confirmed that the transcription level of the CFL1 and RGS3 genes was reduced and the mRNA level of the SEMA4B and LRRC4C genes was elevated by siRNA-induced ZBTB7A silence in HepG2 cells. Those results verified that the CFL1, SEMA4B, RGS3 and DPYSL2 genes, which are implicated in neural development, are directly regulated by the expression of ZBTB7A in HepG2 cells. ZBTB7A may function as a regulator in neural development, and those molecular events associated with the cellular processes remain to be elucidated. Many genes, including Egr-1, c-Krox, CyclinA, E2F4, ADH5, Rb, FANS, p107 and ARF, were identified to be ZBTB7A downstream targets in recent years [4, 10-12, 16, 17] . Of these, E2F4, FANS, ARF and ADH5 were also detected in our global mapping of ZBTB7A binding sites, further supporting the data we obtained from the ChIP-on-chip assay.
Increasing evidence suggests that the ZBTB7A gene is involved in many different physiological processes. In this study, we provide the first overview of the direct targets of the transcription factor ZBTB7A in HepG2 cells by utilizing ChIP-on-chip technology. The global mapping of ZBTB7A binding sites will yield useful information for completely understanding the function of the ZBTB7A gene in cellular processes.
